Genedrive (GB:GDR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Genedrive PLC, a leading pharmacogenetic testing company, announced the successful passage of all proposed resolutions at their recent General Meeting, signaling a positive development for the company. Shareholders can anticipate the Admission of Conditional Placing Shares, Open Offer Shares, and the REX Offer Shares to become effective on June 3, 2024, potentially influencing the company’s stock profile. Genedrive continues to innovate in the point of care testing market with its flagship products, which have received NICE recommendations for use in the UK NHS.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.
